Loading...
XSHG
600436
Market cap9.81bUSD
Jul 10, Last price  
117.05CNY
1D
6.11%
1Q
-22.33%
Jan 2017
155.74%
IPO
88.70%
Name

Zhangzhou Pientzehuang Pharmaceutical Co Ltd

Chart & Performance

D1W1MN
XSHG:600436 chart
P/E
32.71
P/S
7.85
EPS
3.58
Div Yield, %
2.92%
Shrs. gr., 5y
-0.01%
Rev. gr., 5y
6.69%
Revenues
9.00b
-16.56%
522,205,339593,069,218649,743,490694,749,846867,314,5831,021,565,7281,171,153,7371,395,868,5181,453,869,7711,885,674,6732,308,954,2693,713,953,9754,766,156,8925,722,273,4306,510,781,9578,021,550,4508,694,001,50310,058,497,33710,787,863,0909,001,411,806
Net income
2.16b
-27.49%
81,908,17595,188,986140,869,750129,663,236194,131,768254,867,961348,529,666429,768,410438,828,807466,676,727536,131,910807,018,6801,142,932,9201,374,376,8291,671,518,6692,431,899,9362,472,344,7342,797,351,5172,977,002,4892,158,633,052
CFO
77m
-94.14%
50,703,65460,038,07012,573,378129,519,043205,410,719232,950,354162,398,128274,336,209264,499,645305,510,311394,537,198676,933,316612,310,81801,467,076,541462,272,4046,873,030,5802,206,631,5191,313,708,03377,026,625
Dividend
Sep 30, 20251.4 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. is a Chinese company, headquartered in Zhangzhou, that specializes in the production and distribution of traditional Chinese medicines. Its offerings, predominantly sold under the renowned Pien Tze Huang brand, reach consumers both domestically within China and across international markets. Beyond its core pharmaceutical products, the company's expansive portfolio encompasses health and wellness items, beauty care products, household chemical goods, a variety of medical devices, and nutritional supplements. The firm operates as a subsidiary of Zhangzhou Jiulongjiang Group Co., Ltd.
IPO date
Jun 16, 2003
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT